Yasuhiro Ishihara Selected Research

Sulfaphenazole

1/2012	Effects of sulfaphenazole after collagenase-induced experimental intracerebral hemorrhage in rats.
1/2012	Sulfaphenazole attenuates myocardial cell apoptosis accompanied with cardiac ischemia-reperfusion by suppressing the expression of BimEL and Noxa.
1/2010	Effects of sulfaphenazole derivatives on cardiac ischemia-reperfusion injury: association of cytochrome P450 activity and infarct size.
6/2009	Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Ishihara Research Topics

Disease

6	Inflammation (Inflammations) 01/2022 - 01/2013
5	Neoplasms (Cancer) 01/2021 - 01/2013
4	Neuroblastoma 11/2021 - 12/2011
4	Status Epilepticus (Complex Partial Status Epilepticus) 10/2021 - 05/2015
4	Neuroinflammatory Diseases 10/2021 - 01/2015
4	Seizures (Absence Seizure) 01/2019 - 05/2015
3	Edema (Dropsy) 01/2021 - 05/2015
3	Infarction (Infarctions) 01/2018 - 06/2009
3	Brain Edema (Cerebral Edema) 01/2018 - 05/2015
3	Myocardial Infarction 09/2015 - 01/2010
3	Insulin Resistance 05/2015 - 09/2010
3	Ischemia 11/2012 - 01/2010
3	Reperfusion Injury 11/2012 - 06/2009
2	Asthma (Bronchial Asthma) 01/2022 - 10/2018
2	Epilepsy (Aura) 01/2021 - 05/2015
2	Heart Failure 10/2018 - 03/2012
2	Obesity 07/2015 - 07/2014
1	Ischemic Stroke 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Febrile Seizures (Febrile Seizure) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Placenta Accreta 06/2019
1	Placenta Previa 06/2019
1	Lymphoma (Lymphomas) 04/2019
1	Gliosis 01/2019
1	Premature Birth (Birth, Premature) 10/2018
1	Hypersensitivity (Allergy) 06/2018
1	Thrombocytopenia (Thrombopenia) 11/2016
1	Hyperemia 09/2015
1	ST Elevation Myocardial Infarction 09/2015
1	Hyperglycemia 07/2015
1	Hyperlipidemias (Hyperlipidemia) 07/2015
1	Body Weight (Weight, Body) 07/2015
1	Morbid Obesity 07/2015

Drug/Important Bio-Agent (IBA)

5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 06/2009
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2019
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2012 - 06/2009
4	Sulfaphenazole FDA Link 01/2012 - 06/2009
3	RotenoneIBA 11/2021 - 12/2011
3	Pilocarpine (Ocusert)FDA LinkGeneric 10/2021 - 05/2015
3	Docosahexaenoic AcidsIBA 01/2021 - 01/2017
3	Diazepam (Valium)FDA LinkGeneric 01/2019 - 05/2015
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2019 - 05/2015
2	Interleukin-33IBA 01/2022 - 01/2019
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2015
2	CytokinesIBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2012
2	DioxinsIBA 01/2021 - 04/2019
2	ManganeseIBA 06/2019 - 10/2018
2	SeleniumIBA 06/2019 - 10/2018
2	MercuryIBA 06/2019 - 10/2018
2	CadmiumIBA 06/2019 - 10/2018
2	AdipokinesIBA 07/2014 - 09/2010
2	olmesartanIBA 03/2012 - 07/2009
2	Glucose (Dextrose)FDA LinkGeneric 12/2011 - 07/2009
2	Lipid PeroxidesIBA 01/2010 - 06/2009
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	EndotoxinsIBA 01/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2021
1	CarcinogensIBA 01/2021
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2021
1	CytochromesIBA 01/2021
1	Epoxide HydrolasesIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 10/2020
1	MetalsIBA 06/2019
1	Polychlorinated Dibenzodioxins (TCDD)IBA 04/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2019
1	fluorocitrateIBA 01/2019
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2019
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2019
1	Particulate MatterIBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2019
1	EnzymesIBA 01/2019
1	Heavy MetalsIBA 10/2018
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 06/2018
1	PlasticsIBA 06/2018
1	Immunoglobulin G (IgG)IBA 06/2018
1	trimellitic anhydrideIBA 06/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	ChloridesIBA 01/2018
1	Pentylenetetrazole (Metrazol)IBA 01/2017
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2016
1	Mitochondrial DNA (mtDNA)IBA 11/2016
1	Antiphospholipid AntibodiesIBA 11/2016
1	Anticardiolipin AntibodiesIBA 11/2016
1	Adenosine Triphosphate (ATP)IBA 09/2015
1	Nicorandil (SG 75)IBA 09/2015
1	psicose (D-psicose)IBA 07/2015
1	SugarsIBA 07/2015

Therapy/Procedure

2	Therapeutics 09/2015 - 01/2012
2	Ligation 11/2012 - 06/2009
1	Percutaneous Coronary Intervention 09/2015
1	Exercise Therapy (Therapy, Exercise) 07/2015
1	Diet Therapy (Therapy, Diet) 07/2015